文献速递药物不良反应与药物警戒

标准化用药错误相关伤害分类:HAMEC工具

Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC).
PubMed 文献 · Drug Saf · 2019-01-01

该文指出用药错误相关伤害分类缺乏标准化流程,现有工具在评定者间信度和效度上评估不足。作者系统整合现有伤害分类工具的定义要素与优势,开发了用药错误相关伤害分类(HAMEC)工具,并提供明确的应用流程与类别描述,以减少误分类并提高研究间可比性。

要点

  • 现有研究多仅提「错误严重程度」,未区分潜在或实际伤害
  • HAMEC提供明确分类流程与类别描述以减少误分类
  • 工具旨在支持临床与研究场景中伤害分类的可比性

核心结论

  • HAMEC为用药错误相关伤害提供标准化分类工具,适用于临床与研究场景
  • 该工具通过明确应用流程与类别描述降低误分类风险并提高研究间可比性

研究设计与样本

  • 系统综述与工具合成研究,整合现有伤害分类工具的定义要素与优势

主要发现

  • 现有伤害分类工具在研究间差异大,且少有工具评估评定者间信度与效度
  • 许多研究未明确分类的是潜在伤害还是实际伤害,仅提及「错误严重程度」

临床怎么用

  • 在临床与研究中采用HAMEC的明确流程与类别描述进行用药错误伤害分类
  • 分类时需明确区分潜在伤害与实际伤害

局限性

  • 摘要未报告HAMEC的信度与效度评估数据

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Classifying harm associated with a medication error can be time consuming and labour intensive and limited studies undertake this step. There is no standardised process, and few studies that report harm assessment provide adequate methods to allow for study replication. Studies typically mention that a clinical review panel classified patient harm and provide a reference to a classification tool. Moreover, in many studies it is unclear whether potential or actual harm was classified as studies refer only to 'error severity'. The tools used to categorise the severity of patient harm vary widely across studies and few have been assessed for inter-rater reliability and criterion validity. In this paper, we describe the systematic process we undertook to synthesise the defining elements and strengths, while mitigating the limitations, of existing harm classification tools to derive the Harm Associated with Medication Error Classification (HAMEC). This new tool provides a harm classification for use across clinical and research settings. The provision of an explicit process for its application and guiding category descriptors are designed to reduce the risk of misclassification and produce results that are comparable across studies. As the World Health Organisation embarks on its international safety challenge of reducing medication-related harm by 50%, accompanying methodological advances are required to measure progress.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Gates PJ, Baysari MT, Mumford V, et al. Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC). Drug Saf. 2019. PMID: 31016678. doi:10.1007/s40264-019-00823-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。